Sundial Vs. Tilray Vs. Aurora Cannabis: Which Retail-Favorite Cannabis Stock Gave Best Returns In First Half Of 2021?
Shares of Nasdaq-listed cannabis companies such as Tilray Inc. (NASDAQ: TLRY), Sundial Growers Inc.
Nio Schedules Power Day Event For July 9: What To Expect
NIO Inc. (NYSE: NIO) Power, which is a key component of the EV maker's ecosystem, is critical to the success of the company and the uptake of its vehicles.
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment.
How To Watch Playboy Group CEO Ben Kohn Benzinga’s ‘Power Hour’ Today
On Wednesday's edition of the Zingernation Power Hour, "Hot Stocks" Luke Jacobi and Benzinga CEO Jason Raznick will be joined by Playboy Group Inc (NASDAQ: PLBY) CEO Ben Kohn.
Why This BlackBerry Stock Analyst Sees ‘Show Me’ Story Ahead Of Q1 Earnings
BlackBerry Limited (NASDAQ: BB) is scheduled to release its first-quarter results Thursday after the market close.
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries.
Bob Dylan To Star In Streaming Concert On Veeps Platform
Bob Dylan is planning to star in his first broadcast concert in nearly three decades with a presentation on Veeps, the livestream platform division of Live Nation Entertainment Inc. (NYSE: LYV).
PreMarket Prep Stock Of The Day: JPMorgan
Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.
IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings
This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week.
The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs
Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves.